M&A
confidence high
sentiment neutral
materiality 0.85
AnTix Holdings, Inc.: M&A transaction — Innovative MedTech acquires Ticketbash assets for 20M common shares and 115.15M shares via preferred conversion
AnTix Holdings, Inc.
- Issued 20M common shares plus Series A Preferred convertible into 115.15M common shares to Ticketbash.
- Ticketbash owners receive right to appoint two members to Innovative MedTech's Board of Directors.
- Future milestone payments up to $2M based on net revenue and income.
- Ongoing royalty: 2% of revenue up to $15M, 4% of $15M-$25M, 5% above $25M.
- Acquisition closed on April 25, 2025; new subsidiary will operate Ticketbash assets.